Page last updated: 2024-10-24

lymphocyte differentiation

Definition

Target type: biologicalprocess

The process in which a relatively unspecialized precursor cell acquires specialized features of a lymphocyte. A lymphocyte is a leukocyte commonly found in the blood and lymph that has the characteristics of a large nucleus, a neutral staining cytoplasm, and prominent heterochromatin. [CL:0000542, GOC:go_curators]

Lymphocyte differentiation is a complex and tightly regulated process that begins with the commitment of hematopoietic stem cells (HSCs) to the lymphoid lineage. This commitment involves the expression of specific transcription factors, such as GATA-3 and Ikaros, that drive the development of lymphoid progenitor cells. These progenitor cells then undergo a series of developmental stages, culminating in the production of mature lymphocytes, which are essential for adaptive immunity.

The earliest lymphoid progenitors are multipotent and can differentiate into both T and B lymphocytes. However, as these progenitors mature, they become progressively restricted in their developmental potential.

**T cell differentiation:**

* **Double-negative (DN) stage:** T cell progenitors in the thymus are initially CD4- and CD8- negative (DN). They undergo a series of developmental stages within the thymus, characterized by changes in the expression of surface markers and the rearrangement of the T cell receptor (TCR) genes.
* **DN1 (CD44+CD25-):** These early progenitors are still multipotent and can become either T cells or natural killer (NK) cells.
* **DN2 (CD44+CD25+):** These cells express the Notch receptor, which is essential for T cell development.
* **DN3 (CD44-CD25+):** During this stage, the TCR beta chain gene undergoes rearrangement.
* **DN4 (CD44-CD25-):** The TCR alpha chain gene is rearranged, and the pre-TCR complex forms.
* **Double-positive (DP) stage:** DN4 cells express both CD4 and CD8 coreceptors (DP).
* **Single-positive (SP) stage:** The DP cells undergo positive and negative selection based on their TCR affinity for self-antigens. Cells that exhibit strong binding to self-antigens undergo apoptosis (negative selection), while cells that exhibit weak binding to self-antigens survive (positive selection). Cells that survive positive selection become either CD4+ or CD8+ single-positive (SP) T cells, depending on the nature of the TCR and the MHC molecules they interact with.

**B cell differentiation:**

* **Pro-B cell:** The earliest stage of B cell development occurs in the bone marrow. Pro-B cells express the RAG1 and RAG2 proteins, which are essential for VDJ recombination of the immunoglobulin heavy chain (IgH) gene.
* **Pre-B cell:** During this stage, the IgH gene is rearranged, and the pre-B cell receptor (pre-BCR) is formed. The pre-BCR signals the cell to proliferate and undergo further differentiation.
* **Immature B cell:** Immature B cells express a complete immunoglobulin molecule (IgM) on their surface. They undergo negative selection in the bone marrow, and only those that express an IgM receptor that does not bind to self-antigens are allowed to survive.
* **Mature B cell:** Mature B cells migrate from the bone marrow to the peripheral lymphoid organs (lymph nodes, spleen, and Peyer's patches). They are ready to encounter antigens and initiate an immune response.

**Overall, lymphocyte differentiation is a complex and highly regulated process that ensures the production of diverse and functional lymphocytes capable of recognizing and responding to a vast array of pathogens.**'"

Proteins (1)

ProteinDefinitionTaxonomy
DNA-binding protein IkarosA DNA-binding protein Ikaros that is encoded in the genome of human. [PRO:WCB, UniProtKB:Q13422]Homo sapiens (human)

Compounds (4)

CompoundDefinitionClassesRoles
thalidomide2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.

thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.

Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
phthalimides;
piperidones
2-(2,6-dioxopiperidin-3-yl)phthalimidine2-(2,6-dioxopiperidin-3-yl)phthalimidine: thalidomide analog; structure; RN given refers to cpd without isomeric designation
pomalidomide3-aminophthalimidoglutarimide: structure in first sourcearomatic amine;
dicarboximide;
isoindoles;
piperidones
angiogenesis inhibitor;
antineoplastic agent;
immunomodulator
lenalidomidearomatic amine;
dicarboximide;
isoindoles;
piperidones
angiogenesis inhibitor;
antineoplastic agent;
immunomodulator